Nasdaq: KNSA
Kiniksa Pharmaceuticals International insiders
The officers, directors and 10% owners of Kiniksa Pharmaceuticals International, plc who hold the most stock, valued at the live KNSA price.
$93.54
KNSA today −$1.5M (−1.59%)
Market closed. Prices as of Nov 19, 4:04 PM ET
- Ranked insiders
- 4
- Their KNSA stock
- $265M
- Market value
- $7.35B
- Held by ranked insiders
- 3.60%
Insiders by value of KNSA holdings
SEC ownership page| # | Insider | Role | Shares | Value | Of company | Overall rank |
|---|---|---|---|---|---|---|
| 1 | Sanj K. Patel | CHAIRMAN & CEO | 2,606,391 | $244M | 3.32% | 771st |
| 2 | John F. Paolini | CHIEF MEDICAL OFFICER | 114,048 | $10.7M | 0.15% | 8369th |
| 3 | Thomas Malley | Director | 87,312 | $8.2M | 0.11% | 9305th |
| 4 | Richard S. Levy | Director | 22,359 | $2.1M | <0.1% | 8091st |
Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for Kiniksa Pharmaceuticals International; see each profile for the filing.